Full Name | H2 Health |
---|---|
Type | Facility |
Speciality | Clinic/center - Rehabilitation |
Location | 193 Glades Rd, Berea, Kentucky |
Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205192721 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (* (Not Available)) | Secondary |
261QR0400X | Clinic/center - Rehabilitation | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
H2 Health Po Box 932184, Atlanta, GA 31193-4912 Ph: () - | H2 Health 193 Glades Rd, Berea, KY 40403-2261 Ph: (859) 986-1055 |
News Archive
First-String Research, Inc. (FSR), a spin-off biotechnology company from the Medical University of South Carolina (MUSC), has begun the human clinical trial process for its unique, wound-healing peptide gel.
Obesity during pregnancy is associated with greater use of health care services and longer hospital stays, according to a study from the Centers for Disease Control and Prevention (CDC) and Kaiser Permanente Northwest Center for Health Research.
A new 'fertility chip', developed by researchers at the University of Twente's MESA+ Institute for Nanotechnology, can accurately count spermatozoa in sperm. This is an important step towards the development of a compact device for reliable 'pre-scanning' of male fertility. The researchers are publishing the invention of the chip in the scientific journal Lab on a Chip.
Myeloid-derived suppressor cells (MDSCs) are a population of immune cells that have been implicated in tumor resistance to various types of cancer treatment, including targeted therapies, chemotherapy and immunotherapy.
Insmed Inc., a biopharmaceutical company, today reported results for the fourth quarter and full-year ended December 31, 2009.
› Verified 7 days ago